Literature DB >> 16319298

A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease.

Naohiko Uchida1, Hiroshi Ujike, Yuji Tanaka, Ayumu Sakai, Mitsutoshi Yamamoto, Yoshikatsu Fujisawa, Akihiro Kanzaki, Shigetoshi Kuroda.   

Abstract

OBJECTIVE: Some preclinical evidence suggests that the sigma receptor type 1, which plays several roles in learning and memory, may also be involved in the pathogenesis of Alzheimer disease (AD). The authors provide here genetic evidence that the sigma receptor type 1 (SIGMAR1) gene is involved in susceptibility to AD.
METHODS: Two polymorphisms of the SIGMAR1 gene, G-241T/C-240T and Q2P, were analyzed in a Japanese sample of 239 patients with AD and 227 comparisons subjects. These two polymorphisms were in complete linkage disequilibrium with each other, resulting in only two haplotypes, GC-241-240Q2 and TT-241-240P2.
RESULTS: There was a significant association between AD and the TT-241-240P2 haplotype of the SIGMAR1 gene and its homozygote, found with late-onset, but not early-onset AD. After stratification by epsilon4 allele status of the apolipoprotein E gene, TT-241-240P2 homozygosity of the SIGMAR1 gene reduced the risk of AD in epsilon4 allele carriers by three-fourths.
CONCLUSION: The present study suggests that the TT-241-240P2 haplotype of the SIGMAR1 gene, which decreases expression of the gene, may have a protective role against susceptibility to AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319298     DOI: 10.1176/appi.ajgp.13.12.1062

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  14 in total

1.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

Review 2.  Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Shang-Yi Tsai; Tomohisa Mori; Michiko Fujimoto; Tsung-Ping Su
Journal:  Expert Opin Ther Targets       Date:  2011-03-05       Impact factor: 6.902

3.  The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.

Authors:  Daniel Ryskamp; Jun Wu; Michal Geva; Rebecca Kusko; Iris Grossman; Michael Hayden; Ilya Bezprozvanny
Journal:  Neurobiol Dis       Date:  2016-11-03       Impact factor: 5.996

4.  Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PET.

Authors:  Michelle L James; Bin Shen; Carsten H Nielsen; Deepak Behera; Christine L Buckmaster; Christophe Mesangeau; Cristina Zavaleta; Pradeep K Vuppala; Seshulatha Jamalapuram; Bonnie A Avery; David M Lyons; Christopher R McCurdy; Sandip Biswal; Sanjiv S Gambhir; Frederick T Chin
Journal:  J Nucl Med       Date:  2013-12-12       Impact factor: 10.057

Review 5.  Roles of sigma-1 receptors in Alzheimer's disease.

Authors:  Jia-Li Jin; Min Fang; Yan-Xin Zhao; Xue-Yuan Liu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

Review 7.  The sigma-1 receptor: roles in neuronal plasticity and disease.

Authors:  Saïd Kourrich; Tsung-Ping Su; Michiko Fujimoto; Antonello Bonci
Journal:  Trends Neurosci       Date:  2012-10-23       Impact factor: 13.837

Review 8.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

9.  Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.

Authors:  J Hong; S Sha; L Zhou; C Wang; J Yin; L Chen
Journal:  Cell Death Dis       Date:  2015-07-23       Impact factor: 8.469

10.  Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.

Authors:  Daniel Ryskamp; Lili Wu; Jun Wu; Dabin Kim; Gerhard Rammes; Michal Geva; Michael Hayden; Ilya Bezprozvanny
Journal:  Neurobiol Dis       Date:  2018-12-27       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.